Skip to content
  • Home
  • IOncology
  • Infectious Desease Frontier
  • IHepatology
  • Hematology Frontier
  • Conference topics
  • Experts Interviews
  • Informations
  • Live Broadcasting
  • Logout
MediaMedic

Connecting Medical Expertise through Media

  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations
  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations

Top Ten Advances in Hematology in China in 2023

Home » Top Ten Advances in Hematology in China in 2023
Tumor Cell-Released Kynurenine Biases MEP Differentiation into Megakaryocytes in Individuals with Cancer: A Novel Mechanism for Thrombocytosis and Erythrocytopenia

Tumor Cell-Released Kynurenine Biases MEP Differentiation into Megakaryocytes in Individuals with Cancer: A Novel Mechanism for Thrombocytosis and Erythrocytopenia

Posted by By Yin, Jiale 2024.01.22
In December 2023, a study led by Professor Bo Huang  and his team from the Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences, was published in the prestigious international…
Read More
Deciphering STING-Driven Platelet Activation in Septic Thrombosis: A Comprehensive Study Unveiling Molecular Mechanisms and Therapeutic Avenues

Deciphering STING-Driven Platelet Activation in Septic Thrombosis: A Comprehensive Study Unveiling Molecular Mechanisms and Therapeutic Avenues

Posted by By Yin, Jiale 2024.01.22
In May 2023, a study led by Professor JunLing Liu from the School of Medicine, Shanghai Jiao Tong University, was published in the prestigious international academic journal ——Immunity (IF=43.474). The research, titled "STING…
Read More
Single-Cell Dissection of Human Hematopoietic Reconstitution after Allogeneic Hematopoietic Stem Cell Transplantation

Single-Cell Dissection of Human Hematopoietic Reconstitution after Allogeneic Hematopoietic Stem Cell Transplantation

Posted by By Yin, Jiale 2024.01.22
In March 2023, a study led by the team of Professor  Tao Cheng from the Blood Disease Hospital of the Chinese Academy of Medical Sciences (Institute of Hematology, Chinese Academy of…
Read More
The Complexity of Diffuse Large B-Cell Lymphoma: A Revolutionary Genetic Subtyping Algorithm

The Complexity of Diffuse Large B-Cell Lymphoma: A Revolutionary Genetic Subtyping Algorithm

Posted by By Yin, Jiale 2024.01.22
In April 2023, a retrospective study led by Professor WeiLi Zhao  from Ruijin Hospital affiliated to Shanghai Jiao Tong University School of Medicine was published in the prestigious international academic journal ——Signal Transduction and…
Read More
The Role of PD-1 Signaling in T-Cell Acute Lymphoblastic Leukemia: A Revolutionary Breakthrough

The Role of PD-1 Signaling in T-Cell Acute Lymphoblastic Leukemia: A Revolutionary Breakthrough

Posted by By Yin, Jiale 2024.01.22
In January 2023, a  study led by Professor  Meng Zhao   from Zhongshan School of Medicine was published in the prestigious international academic journal ——Nature Cell Biology (IF=21.3). The title of the study is…
Read More
Advancing Precision Medicine in Diffuse Large B Cell Lymphoma: Insights from the GUIDANCE-01 Trial

Advancing Precision Medicine in Diffuse Large B Cell Lymphoma: Insights from the GUIDANCE-01 Trial

Posted by By Yin, Jiale 2024.01.22
In September 2023, a study led by Professor Weili Zhao   from Ruijin Hospital affiliated to Shanghai Jiao Tong University School of Medicine, was published in the prestigious international academic journal ——Cancer Cell (IF=38.585). The…
Read More
The Pan-Cancer Dynamics of Natural Killer Cells: Insights into Heterogeneity and Dysfunction

The Pan-Cancer Dynamics of Natural Killer Cells: Insights into Heterogeneity and Dysfunction

Posted by By Yin, Jiale 2024.01.22
In September 2023, a study led by Professor Zemin Zhang  from Peking University  was published in the prestigious international academic journal ——Cell (IF=64.5). The title of the study is "A pan-cancer single-cell…
Read More
Recent Posts
  • CSCO 2026 | Professor Yanxia Shi: Extending Endocrine-Based Treatment — CDK2/4/6 Inhibition Offers a Therapeutic Option for Mutation-Negative Patients After CDK4/6 Inhibitor Therapy
  • CSCO 2026 | Professor Biyun Wang: From Stratification to Precision — Treatment Strategies After CDK4/6 Inhibitor Resistance and the Clinical Positioning of the CDK2/4/6 Inhibitor Kermoxili
  • CSCO International Perspectives | Professor Kun Wang in Conversation With Professor Pier Paolo Berton Giachetti: From Experience to Evidence — The Path Toward Precision Treatment in Early HER2-Positive Breast Cancer
  • ESMO Preview | Professor Yongmei Yin: A New Breakthrough in HR+/HER2− Advanced Breast Cancer — Iza-bren Ushers in a New Era of Bispecific ADC Therapy
  • Personalized mRNA Vaccine Plus Pembrolizumab Reduces Recurrence and Metastasis in Melanoma
Recent Comments
    Archives
    • October 2026
    • September 2026
    • August 2026
    • July 2026
    • June 2026
    • May 2026
    • April 2026
    • March 2026
    • February 2026
    • January 2026
    • December 2025
    • November 2025
    • October 2025
    • September 2025
    • August 2025
    • July 2025
    • June 2025
    • May 2025
    • April 2025
    • March 2025
    • February 2025
    • January 2025
    • December 2024
    • November 2024
    • October 2024
    • September 2024
    • August 2024
    • July 2024
    • June 2024
    • May 2024
    • April 2024
    • March 2024
    • February 2024
    • January 2024
    • December 2023
    • November 2023
    • October 2023
    • August 2023
    Categories
    • Artificial intelligence
    • Hematology Frontier
    • Infectious Disease Frontier
    • International Hepatology
    • IOncology
    • Live broadcasting
    • Uncategorized
    • UroStream
    • LinkedIn
    • Twitter
    • Mail
    Related Media:
    Copyright 2026 — MediaMedic. All rights reserved. Blogun WordPress Theme
    Paris, France
    Scroll to Top